DMDG 2016 Poster: A Phase I, open-label, 2-Part study to establish absolute bioavailability

Download a copy of our poster titled, 'A Phase I, open-label, 2-Part study to establish absolute bioavailability'. A Phase I, open-label, 2-Part study to establish absolute bioavailability and the ADME of evogliptin in healthy male subjects by light-label approach.